A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study and Open-Label Study to Evaluate the Efficacy and Safety of Abatacept in Combination Therapy With Methotrexate Versus Methotrexate Alone in Subjects With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Abatacept (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Registrational; Therapeutic Use
- Acronyms AIM
- Sponsors Bristol-Myers Squibb
- 11 Jun 2016 Results a post hoc analysis from AIM and ATTAIN and AGREE (n=1536) presented at the 17th Annual Congress of the European League Against Rheumatism
- 01 May 2014 5-years results were published in The Journal of Rheumatology.
- 28 May 2011 Results presented at the 12th Annual Congress of the European League Against Rheumatism.